Status:

COMPLETED

Antenatal Corticosteroid in Elective Cesarean Section

Lead Sponsor:

Assiut University

Conditions:

Cesarean Section Complications

Eligibility:

FEMALE

18-35 years

Phase:

PHASE3

Brief Summary

Caesarean section is a risk factor for the development of neonatal respiratory complications, mostly respiratory distress syndrome (RDS) and transient tachypnoea of the new-born, both in term and pret...

Detailed Description

Infants born at term by caesarean delivery are more likely to develop respiratory morbidity than infants born vaginally, and this risk increases furthermore for the subgroup of children born by electi...

Eligibility Criteria

Inclusion

  • Maternal age (18-35 years)
  • Singleton pregnancy
  • Gestational age (38-40 years)

Exclusion

  • Major maternal morbidities as DM and pre-eclampsia
  • Sever oligohydramnios
  • Premature rupture of membranes
  • Women who receive steroids during pregnancy

Key Trial Info

Start Date :

May 17 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 24 2020

Estimated Enrollment :

498 Patients enrolled

Trial Details

Trial ID

NCT03396107

Start Date

May 17 2018

End Date

May 24 2020

Last Update

June 21 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assiut university

Asyut, Egypt